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Abstract The large amount of data generated using matrix-
assisted laser desorption/ionization mass spectrometric
imaging (MALDI-MSI) poses a challenge for data analysis.
In fact, generally about 1.108–1.109 values (m/z, I) are
stored after a single MALDI-MSI experiment. This imposes
processing techniques using dedicated informatics tools to
be used since manual data interpretation is excluded. This
work proposes and summarizes an approach that utilizes a
multivariable analysis of MSI data. The multivariate
analysis, such as principal component analysis–symbolic
discriminant analysis, can remove and highlight specific
m/z from the spectra in a specific region of interest. This
approach facilitates data processing and provides better
reproducibility, and thus, broadband acquisition for
MALDI-MSI should be considered an effective tool to
highlight biomarkers of interest. Additionally, we demon-
strate the importance of the hierarchical classification of
biomarkers by analyzing studies of clusters obtained either
from digested or undigested tissues and using bottom-up
and in-source decay strategies for in-tissue protein identi-
fication. This provides the possibility for the rapid
identification of specific markers from different histological
samples and their direct localization in tissues. We present
an example from a prostate cancer study using formalin-
fixed paraffin-embedded tissue.
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Introduction
Thirteen years after its original publication [1], matrix-
assisted laser desorption/ionization mass spectrometric
imaging (MALDI-MSI) has become a commonly utilized
tool for imaging endogenous biomolecules [2–5] and
exogenous compounds [6–9] from a diverse array of tissue
types. Since then, many improvements in MALDI-MSI
performance have been achieved, including improvements
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related to tissue preparation [10–12], data processing and
imaging software [13, 14], and spatial resolution [15, 16].
Biomarker discovery and identification has been a field
of intense research over the past 10 years, and MALDI-
MSI has been proven to provide an interesting and
promising strategy for such investigations [17–26].
However, large amounts of data are generated from
imaging, and the manual determination of fine variations
in marker regulation has become an impossible task with
respect to the number of spectra generated (position-
rastered) for a single image (frequently 20,000–40,000
pixels) and the number of images required to obtain a
statistical overview that accounts for the sample variability
between different experiments for a specific tissue and the
intrinsic variability between tissues from different organ-
isms. Moreover, each MS spectrum is composed of a large
number of points (couple (m/z, I)), i.e., in general, a
hundred thousand m/z values with their corresponding
intensity. All together, this corresponds to about 108–
109 m/z values and corresponding intensities for a unique
image. Therefore, an understanding of the fine regulation
of biomolecules to highlight markers of a specific
physiological stage or cell phenotype requires the use of
bioinformatics tools for fast and reliable analyses.
Multivariate statistics is a form of statistics that
simultaneously encompasses the observation and analysis
of more than one statistical variable. Methods of bivariate
statistics, for example, ANOVA and t tests, are special cases
of multivariate statistics that involve two variables. There
are several other types of multivariate analyses that are
divided into two groups: descriptive methods and explor-
ative methods. Descriptive methods include principal
component analysis (PCA), factor analysis of correspon-
dence, multiple correspondence analysis and classification
methods such as hierarchical clustering. Explorative meth-
ods include multiple regression, discriminatory analysis and
segmentation.
Considering the large amounts of data that are analyzed
using the MALDI-MSI approach, data reduction and
multivariable analysis has become a necessity in facilitating
extraction of the information of interest. Among the
different multivariable analytical tools that can be used for
this purpose, PCA has been proven to provide an
interesting method for automatic feature extraction [27].
Several studies have posited arguments that multivariable
analysis though PCA is a good approach for this purpose
and can be used with MALDI-MSI for pathological disease
applications [18, 19, 28–30]. However, some limitations are
associated with the use of PCA. These limitations encom-
pass different factors, such as data analysis complications.
In fact, many spectra can be similar for one principal
component, whereas they can differ for another principal
component, and thus, it is difficult to define the best data
representation. This problem can be resolved by linking
hierarchical clustering directly to PCA [18, 19, 28, 29].
In this paper, we developed a strategy, designated
principal component analysis–symbolic discriminant anal-
ysis (PCA-SDA), to facilitate the identification of bio-
markers. This concept of data mining was also applied to
data sets generated for identification. In fact, protein
identification using direct imaging strategies has been
shown to be possible either by enzymatic digestion using
tissue bottom-up approaches [10, 31, 32] or by in-source
decay (ISD) with top-down approaches [33]. Such strate-
gies also produce large quantity of data, and markers of
interest may be masked within the forest of non-relevant
data. Here, we explored the use of PCA-SDA analysis with
data generated using both bottom-up and ISD. Finally, the
strategy was applied to a biologically relevant case, namely
prostate cancer, using samples from hospital libraries, i.e.,
formalin-fixed paraffin-embedded (FFPE) tissues.
Experimental procedure
Materials
Alpha-cyano-4-hydroxycinnamic acid (CHCA), sinapinic
acid, trifluoracetic acid (TFA), ethanol (EtOH), acetonitrile
(ACN), chloroform, aniline (ANI), (N-succinimidyloxycar-
bonylmethyl)tris(2,4,6-trimethoxyphenyl)phosphonium
bromide (TMPP), water CHROMASOLV PLUS for HPLC
(H2O) were purchased from Sigma-Aldrich (Saint Quentin
Fallavier, France). Sequencing-grade-modified trypsin, por-
cine enzyme was from Promega (Charbonnières-les-Bains,
France)
Tissue preparation and treatment
Frozen tissues
Adult male Wistar rats weighing 250–350 g (animal use
accreditation provided by the French ministry of agriculture
No. 04860) and maintained under standard care were used.
Animals were sacrificed by suffocation under CO2 and
immediately dissected to remove the brain. Tissue sections
(10 μm) were obtained from frozen rat brains tissues using
a Leica CM1510S cryostat (Leica Microsystems, Nanterre,
France) and applied to ITO-coated conductive glass slides
(Bruker Daltonics, Bremen, Germany). Tissues were then
submitted to washing procedures prior to matrix application
for improved detection of peptides/proteins. Washing was
performed by two washing steps using first washing with
cold 95% EtOH for 15 s followed by a washing step with
chloroform for 1 min according to previously published
protocols [11, 34].
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FFPE tissues
Prostate tissue specimens Prostate tissue specimens were
obtained from patients undergoing radical prostatectomy for
clinically localized prostate carcinoma. All patients gave
informed consent according to a protocol approved by the
Internal Review Board for research involving human
subjects at Saint Philibert Hospital. All experiments
involving patient tissues were carried out under approval
number CP 01/33, issued by the Consultative Committee
on Persons Protection in the Biomedical Research of Lille.
None of the patients had any treatment for prostate cancer
before surgery. Prostate tissues were fixed by placing the
samples (2.5 cm×2 cm) for 24–48 h in neutral 3.7% (w/v)
formalin solution, rinsed in PBS buffer and then were
paraffin-embedded which allows tissues to be cut into thin
(i.e., a few micrometers) sections. For MALDI imaging
experiments, 10-μm-thick tissue sections were cut from the
FFPE whole-mount prostate tissue block, placed on the
ITO-coated slides, and heated for 60 min at 58 °C. The
paraffin was then removed by submerging the glass slide in
toluene two times for 5 min, followed by a light rehydration
in ethanol (100, 96; 70, and 30 °C) baths before drying in a
dessicator at room temperature. Tissue was also counter-
stained with Mayer’s hematoxylin, dehydrated through
graded ethanol solutions, and air-dried for the histological
examinations by the anatomopathologists. According to the
anatomopathology examinations, the tissues appeared het-
erogenous and contained cancer, hyperplasiae, and normal
regions in addition to stromal tissues in each region.
Antigen retrieval Antigen retrieval (AR) process was
performed to unmask proteins and ease access of the
enzyme to its specific cleavage sites. Here, AR was
performed using citric acid or so-called citric acid antigen
retrieval (CAAR). CAAR was performed by immersing the
slides in 10 mM of citric acid for 20 min at 90 °C and then
drying them in a dessicator for 10 min. Prior to the
enzymatic digestion, the slides were incubated in 10 mM
NH4HCO3 two times to remove the remaining AR solution
and to condition the tissue for good enzyme activity.
Enzymatic digestion
Automatic trypsin digestions were performed using a high
position accuracy chemical inkjet printer (CHIP-1000,
Shimadzu Biotech, Kyoto, Japan) [10]. The printed array
of the CHIP-1000 on the tissue section comprised spots
spaced 250 μm center-to-center. A total of 20 nL of a
solution containing 25 μg/mL of trypsin in pure H2O was
applied to each spot. Five droplets of approximately 100 pL
were deposited on each spot per cycle. Thus, 40 iterations
were necessary to obtain the final volume. The tissue
sections were then incubated at 37 °C for 2 h in a box with
an atmosphere of saturated MeOH/H2O (1:1, v/v) to avoid
drying the enzyme droplets.
N-terminal derivatization
Automatic TMPP derivatization was performed using the
automatic microspotting device [10]. A CHIP-1000 was
used to deposit TMPP on the tryptic spots according to the
procedure that has been previously described for trypsin
digestion. A total of 10 nL of solution containing 1 mg/mL
of TMPP in ACN/H2O (3:7, v/v) was deposited on each
spot. Five droplets of approximately 100 pL were deposited
on each spot per cycle. Thus, 20 iterations were necessary
to obtain the final volume for each spot. A solution of
ACN/H2O containing 1% TEA was then spotted, thus
initiating the derivatization reaction. The automated micro-
spotting was performed either according to a global square
area of points or by dividing this area into smaller squares,
with each including ten-by-ten spots to increase the reaction
yield [10].
MALDI-MSI
Depending on whether the bottom-up or the ISD
approaches were used, solutions specific for the matrices
were deposited using the CHIP-1000 printer [10] or the
ImagePrep sprayer.
Bottom-up approach
A solid ionic matrix CHCA/aniline was used as the matrix
to image peptides and was prepared according to a
previously established procedure [35].
Matrix microspotting Forty nanoliters of ionic matrix
solution containing 10 mg/mL of CHCA, and 7.2 μL of
aniline in 0.1% ACN/TFA (6:4, v/v) was spotted on each
spot. Five droplets of approximately 100 pL were deposited
on each spot per cycle. Thus, 20 iterations were necessary
to reach the total final volume.
Matrix micro-spraying Five milliliters of a solution con-
taining 10 mg/mL of the matrix CHCA/aniline in 0.1%
ACN/TFA (3:2, v/v) was prepared. The matrix was
deposited on the tissue section with the ImagePrep
automatic sprayer (Bruker Daltonics, Bremen, Germany),
which creates an aerosol via vibrational vaporization and
allows one to monitor the different stages of matrix
deposition, i.e., extraction, drying and matrix layer
thickness. Indeed, the method used to spray CHCA/
aniline included an initialization phase to deposit the first
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layer of the matrix on the slide. This process was
followed by phases that permitted partial moisturization
over several cycles of the tissue section before it had
dried completely. The methods and parameters set-up are
given in Table 1.
MS/MS identification in using bottom-up strategies MS/MS
experiments on digested tissue were performed using the
UltraFlex II MALDI-TOF/TOF instrument equipped with
LIFT III cell using FlexAnalysis 3.0. For MS/MS experi-
ments, parameters were set as follow: laser repetition rate
was 100 Hz, ion source voltages were, respectively, 8 and
7.3 kV on MALDI sample plate and first electrode; LIFT
cell was pulsed from ground for electrodes 1 and 2 to
19 kV and in the last step, electrode 3 was decreased to
3.2 kV; reflector end voltage was set to 29.5 kV and mid-
grid to 13.85 kV. For each MS/MS spectrum, 10,000 total
shots were averaged including 1,000 for parent ions and
9,000 for fragments. Laser fluence was increased over the
experiments for generating lower m/z fragments.
Data analysis Protein identification in databanks were
performed using Biotools 3.0 (Build 1.88) software (Bruker
Daltonics, Bremen, Germany) connected to Mascot 2.2.0.3
search engine and interrogating the Swiss-Prot Protein
Knowledgebase Release 56.1 of 02-Sep-2008 (397,539
sequence entries, comprising 143,289,088 amino acids
abstracted from 172,934 references) with oxidation as
variable modification and no fixed modification. Taxonomy
was specified to be human. Trypsin was selected as enzyme
and one missed cleavages were selected. The mass
tolerance was set at 0.4 and 0.4 Da, respectively, for the
MS and MS/MS.
In-source decay approach
The 1,5-diaminonaphthalene (1,5-DAN)/camphor was used
as the ionic matrix to image ISD fragments of proteins. It
was prepared by adding 1 eqM of cyclic terpenoid camphor
to 5 mg/mL 1,5-DAN in 2% ACN/TFA0 (1:1, v/v).
Matrix microspotting Twenty nanoliters of a solution
containing 5 mg/mL of the matrix 1,5-DAN/camphor in
0.2% ACN/TFA(1:1, v/v) was deposited on an array of
spots that were 100 μm in size and spaced 200 μM in a
hemi rat brain section, using a chemical inkjet printer CHIP
1000 (Shimadzu, Kyoto, Japan).
Matrix micro-spraying Matrix micro-spraying for ISD was
performed following the same protocol as described for
MALDI-MSI and using 5 mL of a solution containing
5 mg/mL of the solid ionic matrix 1,5-DAN/camphor in
ACN/TFA 0.2% (1:1v/v).
Image acquisition Images were acquired using the Ultra-
Flex II MALDI-TOF/TOF instrument. Imaging was per-
formed in the positive reflectron mode, and MALDI-MS
spectra were acquired in the m/z range from 550 to 5,000. A
total of 300 spectra were acquired for each spot at a laser
frequency of 100 Hz. The images were recorded and
reconstructed using Fleximaging 2.1 software.
Statistical analysis The data set obtained with Fleximaging
v2.1 software (Bruker Daltonics, Bremen) was loaded in
the soft ClinProTools v2.2 (Bruker Daltonics, Bremen) to
conduct a principal component analysis and hierarchical
clustering of the data. The unsupervised method was
selected for the PCA after standardization of the data.
Thus, PC1 and PC2 were found to have the largest
variance. After the hierarchical clustering, the same data
were exported to the image in Fleximaging 2.1 to view
areas with different profiles.
Results and discussion
Determining specific markers of a physiological stage or
cell phenotype using MALDI-MSI requires the use of data
processing and data analysis using multivariable analytical
bioinformatics tools. The most widely used multivariable
analysis is PCA. PCA provides access to m/z, which
Table 1 Vibrational micro-sprayer method used for matrix deposition giving method parameters used for the experiments including sensor
control final voltage, number of cycles, spray time, incubation time and dry mode
Sensor control: final voltage difference Number of cycles Spray time Incubation time Dry mode
Phase1: Initialization 0.65 V 5 to 20 2.5 s 10 s 90 s
Phase2 0.1 V 2 to 10 2 s 30 s±30 s 60 s
Phase3 0.2 V 4 to 12 1 s 30 s±30 s Residual wetness
Phase4 0.3 V 3 to 30 1 s 30 s±30 s Residual wetness
Phase5 0.6 V 4 to 64 1 s 30 s±30 s Residual wetness
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demonstrates differences between or within samples. PCA
is often combined with hierarchical clustering (HC),
because HC classifies the mass spectra according to
similarities between their profiles and thus provides the
ability to highlight regions containing differences in
molecular content. Figure 1 describes the general applica-
tion of the analytical workflow to MALDI-MSI data sets.
The first approach of MALDI-MSI data sets is based on
the supervised or non-supervised PCA mode, which allows
the detection of m/z that demonstrate important variations
within the tissue. PCA is conducted using Pareto scaling,
which uses the square root of the standard deviation as a
scaling factor to reduce the dominance of large-scale
intensity changes in the matrix and other high-abundance
ions, which may mask the variation in lower abundance
ions during PCA. The overall outcome of the PCA is
greatly affected by the ability of ions related to the matrix
coating and other endogenous molecules to mask the
underlying, relevant information. For the unsupervised
PCA, each spectrum is classified individually. Thus, the
selected PCs account for the greatest separation of each
individual spectrum. At the top of each, the scores and
loading plots are shown. In the second approach, we
propose the use of hierarchical clustering (Fig. 1) as an
initial step to identify major spectral difference between
each histological type. This method determines the dis-
criminatory signals and builds functions using these signals
that distinguish sample populations based on their classifi-
cation. Peak lists from MALDI spectra, which were
obtained using data processing software (Flex Analysis
v3.0 and Flex Control v2.5), were used for the statistical
analyses and were clustered by similarity discrimination
based on presence vs. absence as criteria. Statistical
analyses were conducted using PCA with ClinProTools
v2.2 software. In this case, the mass spectra were internally
recalibrated on common peaks (also known as a spectral
alignment) and normalized to the total ion count. An
average spectrum created from all of the individual spectra
was used to perform peak selection and to define the
integration ranges. The integration ranges were used to
determine intensities or areas of single spectra. The signal
intensities were used for all calculations. For PCA and HC,
the individual peak intensities were standardized across the
database.
PCA-SDA based on hierarchical clustering for biomarker
identification
PCA-SDA based on HC was first tested using the data sets
from an image generated from a rat brain tissue section
under analytical conditions to detect peptides and small
proteins. Following MALDI imaging acquisition, the data
were loaded in the analytical software for HC (Fig. 2). HC
was prepared using a Euclidean distance method and a
ward linkage method based on the PCA results previously
obtained. The dimensions were reduced to 85% of the
explained variance. A dendrogram was then obtained
(Fig. 2A), which could be translated into a molecular image
by allocating a specific color plot to each of the different
clusters of the HC dendrogram, as presented in Fig. 2B. The
molecular image generated from the HC results could be
Fig. 1 General workflow to search for biomarkers and model
classification by MALDI-MSI
Fig. 2 Hierarchical clustering applied to a frozen rat brain MALDI
image. Colors correspond to the different clusters found in the
dendrogram. A Dendrogram obtained from the image data set. B
Image representation of clusters of the spectra generated by
hierarchical clustering based on the PCA results. C Superposition of
the clustering on the rat brain tissue section optical image
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superimposed on the optical image of the tissue section
(Fig. 2C) and showed a clear correlation of the different
clusters to the histological tissue types. Each group of
spectra delimitating a cluster differed from other groups
based on spectral profiles convergence for classified in the
same cluster and divergence for spectra classified in
different clusters (Fig. 2B). This is a good method to define
regions corresponding to various cell phenotypes and
subsequently markers of these specific phenotypes. We,
therefore, used HC to define our regions of interest (ROI’s).
To exemplify this, we created a ROI (Fig. 3) in the rat brain
section for the fourth ventricle. Here, we choose to enclose
in the ROI a slightly larger area than the fourth ventricle to
include spectra with different profiles for serving as
negative controls (Fig. 3A). Spectra for this region were
then selectively loaded for PCA multivariate analysis
(Fig. 3B). After PCA analysis, the PC1 versus PC2 loading
was performed to compare m/z that were differentially
detected in the selected ROI because PC1/PC2 provided the
best discrimination. Several different ions presented a high
level of discrimination along the PC1 axis. To perform a
study case, two ions with a high level of discrimination and
that presented a very different distribution within the tissue
sections were selected: ions at m/z 2,030 and m/z 2,793. As
demonstrated by the superimposition of the MALDI images
of these ions onto the optical image of the tissue section
(Fig. 3C and D), these ions had a very different distribution.
In fact, m/z 2,030 was specific to the fourth ventricle
(Fig. 3C), whereas m/z 2,793 (Fig. 3D) demonstrated a
relatively large distribution within the tissue section that
corresponded to other morphological structures in the
tissue. m/z 2793 was absent in the fourth ventricle but
present in the area obtained from the ROI around the
structure, which served as a negative control. The MALDI-
Fig. 3 Selection of a cluster representing the ROI. A The spectra for
this region were loaded for a new PCA analysis to provide the
different m/z variations. B Examples of images at m/z with different
distributions, as demonstrated by the PCA analysis. C–D Images of
the distributions at m/z 2030 and m/z 2793, respectively
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MSI results are usually obtained from the average mass
spectrum, which is reconstructed from all of the spectra
recorded during the image acquisition using the software.
Therefore, by using such a representation of the data, the
m/z present in a small region (i.e., in a few spectra) are not
properly represented in the average mass spectrum, even if
they are very intense. This lack of information is exempli-
fied by the signal at m/z 2,793, is not observed in the
average mass spectrum (Fig. 4A) and precludes the
reconstruction of an image. However, as shown in
Fig. 4B, it was possible to detect this ion specifically in
the fourth ventricle using the PCA-SDA analytical ap-
proach described herein (Fig. 4C), which is in contrast to
other regions (Fig. 4D).
Thus, without the PCA-SDA approach, it would not
have been possible to detect the presence of this marker,
which is highly specific to the 4th ventricle. This shows
that PCA-SDA facilitates the direct tracking of specific
markers in an ROI defined by the HC analysis. As
compared to other proteomic techniques, this will greatly
affect the MSI. In fact, the great potential of MSI coupled
with PCA-SDA is reflected by the ability to quickly detect
specific markers that are present in a pathological region or
in regions containing cells with diverse phenotypes while
conserving their spatio-temporal localization in the tissue.
These signals would be diluted using classical proteomic
strategies in which whole organs are used for extraction.
For all experiments performed on rat brains, biological
material was easily accessible and these experiments were
performed in triplicate from adjacent tissue section from the
same tissue block and from five different brain tissues from
different animals. Similar results were obtained from the
multivariate analysis approach from the different experi-
ments. However, only some examples on various tissues are
presented here. The next step is the identification of the
detected markers in tissues. Therefore, we were interested
in testing the PCA-SDA strategy using data generated from
identification strategies.
Bottom-up approach
The bottom-up strategy was the first technique explored for
on-tissue protein identification [10, 32, 35, 36]. This is
explained principally based on two factors: it is difficult to
use a proper top-down analysis with ion selection on
MALDI instruments, and archived clinical samples (FFPE)
cannot be used for MSI without a digestion step [35, 37,
38]. Therefore, marker screening from a classical MSI
sequence is performed. However, bottom-up and classical
approaches have been shown to lead to complementary data
with proteins specifically observed in one strategy. More-
over, marker screening for archived FFPE samples can only
be performed using digestion data. Therefore, the validity
of statistical analyses from such data, which could be
hampered by a slight delocalization of markers due to the
type of tissue preparation, must be investigated.
PCA and HC from enzymatic digestion data To evaluate
the digestion data, a rat brain tissue section (interaural,
7.20 mm, bregma, 1.80 mm) was subjected to trypsin
digestion prior to matrix deposition (Fig. 5A and C). After
PCA analysis, hierarchical clustering was applied to the
data set. The results of the clustering are presented in
Fig. 5B, and the dendrogram is shown in Fig. 5D. The image
reconstructed from the clustering demonstrated a good
correlation with the different brain areas determined in the
brain section (Fig. 5A, C). The presented images had a low
resolution due to one of the drawbacks of the software used
(the number of data points accepted by the software).
Therefore, HC imaging analysis data sets with a poor
resolution (962 points at 250 μm) were recorded. This
confirmed that a bottom-up strategy could be used for
protein identification in tissues and was statistically
relevant.
HC and N-terminal derivatization To simplify the protein
identification procedure, derivatization strategies were
Fig. 4 AMALDI images of the average spectrum with a zoom in the m/z range of the ions at m/z 2,793, which are non-detectable. B Image of the
m/z 2,793 ion distribution. C–D Single MALDI spectra recorded in the region where m/z 2793 is found (C) and not found (D)
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developed in the group to be performed on digestion
peptides [32]. N-terminal chemical derivatization of
peptides was developed in order to help in proteins
identification by unambiguous determination of digestion
peptides primary sequence. In fact addition of specific
chemicals at the N-terminus of peptides, in peculiar
positively or negatively charged groups, have shown to
increase fragmentation ion yields and lead to orientation
of fragmentation towards specific ion fragment series.
This results in MS/MS spectra of much easier interpre-
tation even for de novo sequencing, giving more
confident identifications. Previously, several derivatiza-
tion procedures were developed to be performed in situ
at the tissue level [32] showing the interest of both
derivatization by negative charge (derivatization with 4-
SPITC (4-sulfophenyl isothiocyanate) or 3-SBASE (3-
sulfobenzoic acid succinimidyl ester)) or positive charge
(addition of TMPP (N-succinimidyloxycarbonylmethyl)-
tris(2,4,6 trimethoxyphenyl)phosphonium bromide).
Although if all derivatizations were usable at the global
tissue level, only TMPP was found to be easily compatible
with automatic micro deposition methods preventing
delocalization of peptides during the derivatization process
and subsequently allowing images to be recorded. There-
fore, TMPP derivatization was chosen here to be used for
multivariate analysis studies. In the present study, we
tested PCA and HC on MALDI imaging data recorded
from a rat brain tissue section (interaural, 4.84 mm,
bregma, 4.16 mm) following micro-spotting trypsin
digestion and then micro-spotting TMPP derivatization,
as compared to micro-spotting of trypsin alone (Fig. 6). In
this experiment, two distinct areas that were symmetrical
according to the symmetry axis of the rat brain were
digested (Fig. 6B) and then derivatized (Fig. 6C). As
demonstrated, the classification resulting from HC dis-
criminated two regions, each of which was represented by
a branch of the dendrogram. The first branch (red)
corresponds to the cortex, whereas the second branch
(blue) corresponds to the spectra depicting the corpus
callosum. From the two dendrograms, it is clear that
enzymatic digestion alone and enzymatic digestion fol-
lowed by N-terminal chemical derivatization provide the
same data classification. This result demonstrates that all
types of data can be used for statistical analysis if the data
is of sufficient quality, i.e., if the particular treatment used
does not induce delocalization of the molecules.
In-source decay approach
The bottom-up approach is the most advanced and most
widely used technique for protein identification and
characterization because most instruments permit fragmen-
tation of the amino acid sequence in the mass range of 500–
3,500. Nevertheless, there are several fundamental and
practical limitations to the bottom-up strategy. Most
importantly, only a fraction of the total peptide population
for a given protein is identified, and therefore, only a
portion of the information for the protein sequence is
provided. It is clear from genomic studies that each open-
reading frame can give rise to many protein isoforms that
originate from alternatively spliced products, and each
isoform can present different types and locations of
posttranslational modifications (PTMs). PTMs such as
phosphorylation and glycosylation are known to be
important in the regulation of protein function and cell
Fig. 5 A Optical image and C
image from the brain atlas of the
rat brain tissue section used in
the bottom-up experiment with
on-tissue trypsin digestion. D
HC dendrogram showing the
differentiation of the different
histological images and B HC
image reconstructed from HC
dendrogram data
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metabolism. A consequence of the limited sequence
coverage in bottom-up proteomics is the global loss of
information, including information concerning PTMs. In
contrast, the top-down strategy provides potential access to
a large part, and sometimes all, of the protein sequence,
including its PTMs [39–45]. In addition, the time-
consuming protein digestion step required for the bottom-
up method is eliminated.
Classical top-down strategies are not possible using
MALDI instruments because the instrumentation used for
such purposes is not compatible with the very low charge
states observed in MALDI. However, the top-down method
without ion selection can be used with MALDI to rapidly
generate fragmentation using ISD [39–46]. ISD has been
demonstrated previously [33] for tissue sections. However,
because ISD is not used with ion selection, the resulting
mass spectra are extremely difficult to interpret. Here, we
tested the ability of HC and PCA to facilitate interpretation
of the ISD data. A previous publication has demonstrated
the advantage of using a 1,5-DAN matrix for protein
sequence and glycosylation characterization. The 1,5-DAN
matrix is a good proton donor and tends to fragment
proteins from their C-terminal region to produce ci+ and zi+
fragment ions [47]. In the present study, we developed a
specific solid ionic matrix (1,5-DAN/camphor) to achieve
better reproducibility, sensitivity and deposition facility by
micro-spraying or micro-spotting of the matrix for ISD
from tissues. We found that adding the camphor cyclic
terpenoid to the classical 1,5-DAN matrix resulted in
average spectra with more intense peaks, which were found
to be ISD ions. This process facilitated the detection of ions
that corresponded to the tags used for protein identification
in the images (Electronic Supplementary Material Fig. S1).
This ionic matrix was also used for instrumentation
preservation, and it demonstrated greater solubility in
solvents that are classically used with automated micro-
spraying and micro-spotting devices; 1,5-DAN alone was
shown to be a matrix with a high level of deterioration for
the deposition instruments.
PCH and HC for ISD-MALDI-MSI Clustering images
(Fig. 7) were generated from the obtained MALDI images
using 1,5-DAN/camphor, and subsequently, prompt frag-
ments were obtained from whole proteins in the section at
each position. Two different deposition methods for the
matrix, the micro-spotter and the micro-sprayer, were used.
The hierarchical clustering results are shown in Fig. 7A and C.
The histological regions corresponding to the clusters are
demonstrated symmetrically in Fig. 7B and D. We note that
the classification of the spectra correlated with the
histological areas of the tissue section. These clusters
would not be detected if there were no differences between
the spectra determined for each area. Therefore, it is
possible to classify the specific ions by PCA and to
reassemble them with greater ease to identify proteins of
interest while suppressing common ions of the different
Fig. 6 A Optical image of a rat
brain tissue section presenting
two pitches that are symmetri-
cally distributed and that corre-
spond to a specific tissue
preparation: enzymatic digestion
(left) and enzymatic digestion
followed by TMPP derivatiza-
tion (right). HC was applied to
the MALDI-MSI data for the
two conditions, and the
corresponding dendrogram and
reconstructed images are pre-
sented B for trypsin digestion
and C for trypsin digestion
followed by TMPP
derivatization
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class (common proteins). Unfortunately, we identified only
myelin in the cingulum region of the rat brain section
(Electronic Supplementary Material Fig. S1) using this
technology. Moreover, it was often difficult to analyze
properly one of the amino acid sequences within a spectrum
ISD due to the large number of peaks that were detected for
the different proteins. Thus, using HC, we were able to
identify differences between histological regions and PCA,
which permitted the efficient detection of differences in the
complexity of the ISD spectra. Importantly, ISD can be only
performed using frozen tissue (never formalin-fixed
paraffin-embedded tissues), and only major proteins with a
high abundance can be detected. The developments of on-
tissue depletion methods are clearly necessary to further the
uses of such techniques.
PCA and HC in the bottom-up approach: application
to FFPE prostate cancer tissues
The opportunity to investigate archived FFPE tissues will
pave the way toward a gold mine of tissue samples that are
stored in pathological institutes for retrospective studies.
Consequently, many efforts by others and by our group [35,
37] have been implemented to find a strategy to analyze
tissues using MALDI-MSI [37, 48–50]. Most of the
libraries are builds of FFPE tissues because this preserva-
tion protocol produces well-conserved morphology and
high stability along time avoiding degradation of mole-
cules. However, the major difficulty associated with such
tissue is the occurrence of protein cross-linking due to
tissue fixation. Indeed, formalin creates methylene bonds
between proteins and prevents direct tissue analysis by
MALDI-MSI. To circumvent this problem, enzymatic
digestion using, for example, trypsin is used to obtain and
to identify protein fragments, and therefore, a bottom-up
approach is used [35]. Because cross-linking is still
pursuing in FFPE tissue blocks during conservation period,
protein accessibility becomes more difficult over time, and
enzyme cleavage can be affected leading to poor enzymatic
yields. Therefore, it is necessary to establish processes that
facilitate access to proteins. Similar challenges are encoun-
tered for HIC of FFPE samples. Over time, many different
protocols have been developed to unmask antigen epitopes
[24, 51–60]. These so-called AR processes are still not well
understood in terms of the associated molecular changes.
The most reasonable hypothesis is that AR allows changes
in the conformation of cross-linked proteins and thus
facilitates access to sites within the proteins. To date, many
different AR protocols have been published [24, 51–60].
However, according to the nature of the tissue used and the
protein (antigen) under consideration, some protocols work
better than others which are not yet well understood.
Consequently, systematic tests of different AR protocols are
required to define the best protocol. Here, we have tested
several AR processes on prostate cancer FFPE tissues
including EDTA pH 8 hot baths or in a pressure cooker,
heat-induced AR using microwave and citric acid pH 6 or
CAAR in a hot bath. CAAR was found to provide better
results for prostate cancer tissue sections with respect to
trypsin digestion approach. We have performed a bottom-
up analysis of FFPE tissue from grade IV prostate cancer
samples using trypsin as the enzyme and HCCA/ANI as the
matrix, with a micro-spraying device. In a grade IV
Fig. 7 HC analysis performed
for MALDI-MSI data recorded
in ISD from a rat brain tissue
section using a 1,5-DAN/cam-
phor ionic matrix deposited with
an automatic micro-spotter (A)
and with an automatic micro-
sprayer (C). (B and D)
Schematic representation of the
spectral classification for each
cluster. Green: cingulum, red:
dentate gyrus, blue: combina-
tion of cerebral cortex and
hippocampus
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carcinoma section, several histological cell types were
observed that resembled tumor or stroma with normal acini
(close to normal) regions, as classified by the pathologist.
Thus, the spectra of these two specific regions were
collected before they were exported for the HC and PCA
analyses (Fig. 8A). The dendrogram from the hierarchical
clustering divides the spectra into two branches. The
locations of these branches are shown in Fig. 8B. Classi-
fication of the spectra correlated with their histological
origin (cancer grade IV in red vs. stroma with acini in
green; Fig. 8B). This ranking suggests that it is possible to
use the MS profiles (in this context, peptides and proteins)
as a “signature” for cell phenotype classification or MSI
histology, and it may allow the development of a new
diagnostic approach based on the molecular signature and
not on a specific biomarker alone. To illustrate this idea,
two ROIs (ROI1 and ROI2) that were determined in
different regions of the tissue were added to the analysis
(Fig. 8C) together with the previous regions. HC analysis
was performed for these four regions. The resulting HC
dendrogram revealed an initial separation into two branches
and then a sub-division of each of these branches into two
others. The first two branches (first division) were
represented as an image on the tissue (Fig. 8D). In
Fig. 8D, grade IV tumor and stroma with acini clusters
can still be observed as distinct areas, with each area
corresponding to a branch. However, it should be noted that
the ROI1 spectra appear close to the stroma and tumor
profiles, whereas ROI2 has a profile that is closer to the
tumor alone. However, based on the sub-branch dendro-
gram analysis (Fig. 8E), we note that the turquoise blue
cluster of ROI2 differs from the red cluster of the tumor and
correspond to a sub-division. In contrast, ROI1 consistently
shows a signature that is closer to the tumor and the stroma
with acini. Therefore, it is possible to use the same
approach for different biopsies and to correlate the
signatures of the clusters obtained for the examined
histological areas using a bank of peptide/protein signatures
Fig. 8 HC analysis of FFPE prostate cancer tissue after on-tissue
trypsin digestion. A Delimitation of stroma with acini and cancer
grade IV regions on the optical image of the tissue. B HC results
(dendrogram and image) for the cancer and stroma with acini spectra.
C Delimitation of the new ROIs on the optical image of the tissue.
D–E HC results (dendrogram and image) for four regions (stroma +
acini, cancer, ROI1 and ROI2)
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generated from tissues for which the pathologic stages are
known.
The spectral classification for the grade IV tumor and
stroma with acini area also supports the conclusion that
specific m/z are related to the histologic classification. The
PCA-SDA strategy can be performed to track markers for
each cell phenotype (Fig. 9A). The score plot (Fig. 9B) and
loading plot (Fig. 9C) obtained after supervised PCA
analysis provides a list of m/z that are specific to each area
(Fig. 9D), determining clusters. Images of the ions detected
in the stroma with acini are presented in Fig. 9E, and those
detected in the tumor region are shown in Fig. 9F. To further
understand the progression of cancer, it is of primary
importance to identify the ions detected for each cell
phenotype, i.e., tumor vs. stroma + acini. As described
previously, enzymatic digestion does not lead to delocal-
ization and allows a hierarchical classification. The PCA
analysis related to the tissue type to be performed to
highlight the presence of specific markers in the different
cell types. Therefore, the bottom-up approach could be
Fig. 9 Supervised PCA analysis of prostate cancer grade IV FFPE
tissue after on-tissue trypsin digestion. A Optical images indicating the
stroma with acini and cancer grade IV regions. B Score plot (green:
stroma with acini spectra, red: cancer grade IV spectra). C Loading
plot. D List of m/z specific for each region. E–F MALDI-MSI images
of the ions determined by PCA in the stroma with acini (E) and in the
tumor region (F)
Fig. 10 A MALDI-MSI molecular images of several fragments of
actin tryptic fragments detected by PCA-SDA from the tissue section
after AR and trypsin digestion, B MS/MS spectra of these actin tryptic
fragments and C sequence coverage if these four fragments on the
actin protein sequence. These images and MS/MS data were generated
from the adjacent tissue section of the same patient biopsy used in the
experiments corresponding to images presented Fig. 9
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useful for analyses of FFPE tissues from pathologist
libraries. Some ions obtained using PCA-SDA were directly
identified in the tissue section after the CAAR antigen
retrieval procedure by MS2 using the MALDI-TOF/TOF
instrument. A second experiment was performed from the
adjacent tissue section of the FFPE biopsy block. Same MS
profiles were again observed with an identical correlation of
ions distribution with respect to the morphology of the
tissue according to cell phenotypes. From this tissue MS2
experiments were undertaken for identification of proteins.
MS2 was performed for precursor ions at m/z 944.4,
1,180.54, 1,623.21, 1,743.79, 1,790.08, 2,227.30, and
3,196.48 (Figs. 10 and 11). These ions correspond to actin
fragments (Fig. 10B) or to histone H4, histone 2A type 1-A,
and histone 2B type 1-B (Fig. 11). Interestingly, all of the
actin fragments were specifically localized in the tumor
region and not in the stroma with normal acini, which is
consistent with the PCA-SDA results (Fig. 10A), whereas
the histone fragments were localized in the stroma with
acini (Fig. 8E). The ions related to actin present in the tumor
region presented sequence coverage of 21.5% and were
localized to the C-terminal portion of the protein, which
suggested that the N-terminal portion of the protein was
less accessible due to the presence of methylene bonds or to
[A]






Histone H2B type 1-B
m/z 1743.79
AMGIMNSFVNDIFER
Fig. 11 MS/MS spectra
recorded from prostate cancer
FFPE tissue sections after AR
and trypsin digestion of three
different ions (three histones)
found by PCA-SDA to be
specifics of the stroma with
acini region
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protein truncation (Fig. 10C). All the identified proteins,
related tryptic peptide sequences, identification scores and
Mw are summarized in Table 2. Ions attributing to the
different MS/MS spectra corresponding to the different
tryptic fragments studied are summarized in Electronic
Supplementary Material Table S1. These experiments were
reiterated on another FFPE block from a different patient
performing experiments in triplicate from adjacent tissue
slices. Similar results were obtained from this second
patient. Identical ions were observed from this biopsy and
ions distribution were again correlated to the same cells
according to their morphological type (cell phenotype) The
presence of actin in the tumor region is consistent with the
cytoskeletal remodeling that occurs during prostate cancer
development together with muscle contraction. The detec-
tion of histone types in the stroma with acini seems to
indicate mitotic and apoptotic indices for these cells, which
reflects the possibility that their phenotype is more similar
to benign than to healthy cells. These data are consistent
with the results obtained for other cancers, such as breast
[50] or ovarian [18] cancers. Interestingly, we showed that
based on the 150 m/z detection using PCA-SDA in the
tumor region, only four were related to actin. This result
supports the finding that not only major proteins can be
detected using the bottom-up strategy. These findings
highlight the necessity to develop new approaches to gain
access to the minor m/z detected using PCA-SDA. In fact,
AR followed by enzymatic digestion is not sufficient for the
identification of these markers or for other minor ones.
Nevertheless, several MS/MS studies have been performed,
and identification problems have been encountered due to
the methylene bridges that occur between proteins. In fact,
in some cases, MS/MS spectra were uninterpretable and did
not provide any identification results. This phenomenon
was presumably attributed to the presence of cross-linked
peptides that were linked by a methylene bridge. Thus,
fundamental investigations are necessary to fully under-
stand the chemistry of fixation and the formation of
methylene bridges to develop the appropriate software for
MS/MS spectral analysis from FFPE tissues.
Conclusion
The PCA-SDA based on hierarchical clustering represents
an excellent, fast, and reproducible technique for the
analysis of MSI data to search for markers. We showed
that this approach is useful after different tissue treatments,
such as enzyme digestion and N-terminal derivatization,
which are used in bottom-up strategies for the direct
identification of ions of interest in the tissue. Thus, it is
possible to combine the MALDI-MSI and bottom-up
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via enzymatic digestion, derivatization, and PCA-SDA
based on hierarchical clustering for protein fragment
detection and identification. All of these steps can be
performed for the same tissue and in only one experiment.
Data obtained using the top-down method with ISD can
also be used for PCA-SDA following on-tissue depletion to
highlight proteins other than the major ones. In the near
future, the most promising development will be the
emergence of databases that are based on approaches using
these statistical models. The creation of mathematical
models that represent histological groups could enable a
significant advance for molecularly based diagnostic and
prognostic studies.
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